These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 36725842)
1. LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1-TINCR-USP20-PD-L1 axis. Wang Q; Li G; Ma X; Liu L; Liu J; Yin Y; Li H; Chen Y; Zhang X; Zhang L; Sun L; Ai J; Xu S Cell Death Dis; 2023 Feb; 14(2):76. PubMed ID: 36725842 [TBL] [Abstract][Full Text] [Related]
2. LncRNA TINCR favors tumorigenesis via STAT3-TINCR-EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer. Wang Q; Liu J; You Z; Yin Y; Liu L; Kang Y; Li S; Ning S; Li H; Gong Y; Xu S; Pang D Cell Death Dis; 2021 Jan; 12(1):83. PubMed ID: 33446634 [TBL] [Abstract][Full Text] [Related]
3. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1. Selem NA; Nafae H; Manie T; Youness RA; Gad MZ Pathol Res Pract; 2023 Aug; 248():154579. PubMed ID: 37301086 [TBL] [Abstract][Full Text] [Related]
4. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis. Zhang H; Zhu C; He Z; Chen S; Li L; Sun C J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166 [TBL] [Abstract][Full Text] [Related]
5. The miR-199a-5p/PD-L1 axis regulates cell proliferation, migration and invasion in follicular thyroid carcinoma. Lin J; Qiu Y; Zheng X; Dai Y; Xu T BMC Cancer; 2022 Jul; 22(1):756. PubMed ID: 35818041 [TBL] [Abstract][Full Text] [Related]
6. lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune response. Zhang X; Pan B; Qiu J; Ke X; Shen S; Wang X; Tang N Int J Exp Pathol; 2022 Jun; 103(3):102-111. PubMed ID: 35429078 [TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts-derived exosomes promote lung cancer progression by OIP5-AS1/ miR-142-5p/ PD-L1 axis. Jiang Y; Wang K; Lu X; Wang Y; Chen J Mol Immunol; 2021 Dec; 140():47-58. PubMed ID: 34653794 [TBL] [Abstract][Full Text] [Related]
8. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1. Zhang M; Xu Y; Yin S; Qiu F Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis. Zhao H; Xie Z; Tang G; Wei S; Chen G J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189 [TBL] [Abstract][Full Text] [Related]
10. LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway. Du L; Wang B; Wu M; Chen W; Wang W; Diao W; Ding M; Chen W; Cao W; Guo H; Zhang G Cancer Lett; 2023 Dec; 578():216463. PubMed ID: 37866544 [TBL] [Abstract][Full Text] [Related]
11. Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis. Li C; Pan B; Wang X; Liu X; Qin J; Gao T; Sun H; Pan Y; Wang S J Cancer Res Clin Oncol; 2022 Aug; 148(8):1965-1982. PubMed ID: 35357586 [TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression. Peng L; Pan B; Zhang X; Wang Z; Qiu J; Wang X; Tang N Cell Biol Toxicol; 2022 Dec; 38(6):1159-1173. PubMed ID: 35438468 [TBL] [Abstract][Full Text] [Related]
13. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer. Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694 [TBL] [Abstract][Full Text] [Related]
14. [Plasma exosomal miR-335-5p serves as a diagnostic indicator and inhibits immune escape in triple-negative breast cancer]. Chen T; Dong Y; Wu X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Apr; 38(4):347-356. PubMed ID: 35583065 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p. Zhou WY; Zhang MM; Liu C; Kang Y; Wang JO; Yang XH J Cell Physiol; 2019 Dec; 234(12):23176-23189. PubMed ID: 31206665 [TBL] [Abstract][Full Text] [Related]
16. Oleuropin controls miR-194/XIST/PD-L1 loop in triple negative breast cancer: New role of nutri-epigenetics in immune-oncology. Hamed MM; Handoussa H; Hussein NH; Eissa RA; Abdel-Aal LK; El Tayebi HM Life Sci; 2021 Jul; 277():119353. PubMed ID: 33798547 [TBL] [Abstract][Full Text] [Related]
17. microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1. Jiang K; Zou H Bioengineered; 2022 Jan; 13(1):917-929. PubMed ID: 34968160 [TBL] [Abstract][Full Text] [Related]
18. LncRNA Xu YJ; Zhao JM; Ni XF; Wang W; Hu WW; Wu CP Epigenomics; 2021 Aug; 13(16):1281-1297. PubMed ID: 34523356 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer. Liu Y; Du Y; Hu X; Zhao L; Xia W BMC Cancer; 2018 Apr; 18(1):367. PubMed ID: 29614984 [TBL] [Abstract][Full Text] [Related]
20. Yin Yang 1-stimulated long noncoding RNA bladder cancer-associated transcript 1 upregulation facilitates esophageal carcinoma progression via the microRNA-5590-3p/programmed cell death-ligand 1 pathway. Cheng J; Yang Q; Han X; Wang H; Wu K; Zhao H Bioengineered; 2022 Apr; 13(4):10244-10257. PubMed ID: 35435118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]